For: | Kim YJ, Kim BK, Park SJ, Kim JH. Impact of Fusobacterium nucleatum in the gastrointestinal tract on natural killer cells. World J Gastroenterol 2021; 27(29): 4879-4889 [PMID: PMC8371507 DOI: 10.3748/wjg.v27.i29.4879] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i29/4879.htm |
Number | Citing Articles |
1 |
Ying Zhang, Xiaohan Xiang, Shaolan Zhou, Duygu Altinok Dindar, Stephanie Wood, Zhenzhen Zhang, Baoen Shan, Lianmei Zhao. Relationship between pathogenic microorganisms and the occurrence of esophageal carcinoma based on pathological type: a narrative review. Expert Review of Gastroenterology & Hepatology 2023; 17(4): 353 doi: 10.1080/17474124.2023.2189099
|
2 |
Ritis K. Shyanti, Jazmyn Greggs, Shalie Malik, Manoj Mishra. Gut dysbiosis impacts the immune system and promotes prostate cancer. Immunology Letters 2024; 268: 106883 doi: 10.1016/j.imlet.2024.106883
|
3 |
Sarra B. Shakartalla, Tasneem M. Elsayed, Fatimah Almsailem, Fatma Almousa, Aseel Aldaihani, Sameh S. M. Soliman. Metabolic Dynamics in Host-Microbe Interaction. 2025; : 411 doi: 10.1007/978-981-96-1305-2_16
|
4 |
Xiaoyan Duan, Ping Chen, Xiaoxia Xu, Meiling Han, Jianbo Li, Stefania Cantore. Role of Gastric Microorganisms Other than Helicobacter pylori in the Development and Treatment of Gastric Diseases. BioMed Research International 2022; 2022(1) doi: 10.1155/2022/6263423
|
5 |
Alexa Little, Mark Tangney, Michael M. Tunney, Niamh E. Buckley. Fusobacterium nucleatum: a novel immune modulator in breast cancer?. Expert Reviews in Molecular Medicine 2023; 25 doi: 10.1017/erm.2023.9
|
6 |
Hongzhi He, Yu Hao, Yu Fan, Bolei Li, Lei Cheng. The interaction between innate immunity and oral microbiota in oral diseases. Expert Review of Clinical Immunology 2023; 19(4): 405 doi: 10.1080/1744666X.2023.2182291
|
7 |
María Belén Novoa Díaz, María Julia Martín, Claudia Gentili. Tumor microenvironment involvement in colorectal cancer progression <i>via</i> Wnt/β-catenin pathway: Providing understanding of the complex mechanisms of chemoresistance. World Journal of Gastroenterology 2022; 28(26): 3027-3046 doi: 10.3748/wjg.v28.i26.3027
|
8 |
Suwen Ou, Hufei Wang, Yangbao Tao, Kangjia Luo, Jinhua Ye, Songlin Ran, Zilong Guan, Yuliuming Wang, Hanqing Hu, Rui Huang. Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism. Frontiers in Cellular and Infection Microbiology 2022; 12 doi: 10.3389/fcimb.2022.1020583
|
9 |
Tomasz M. Karpiński, Marcin Ożarowski, Mark Stasiewicz. Carcinogenic microbiota and its role in colorectal cancer development. Seminars in Cancer Biology 2022; 86: 420 doi: 10.1016/j.semcancer.2022.01.004
|
10 |
Qing Gu, Jiaqian Yan, Yeqing Lou, Zihao Zhang, Yonglu Li, Zichun Zhu, Manman Liu, Danli Wu, Ying Liang, Jiaqian Pu, Xiaodan Zhao, Hang Xiao, Ping Li. Bacteriocins: Curial guardians of gastrointestinal tract. Comprehensive Reviews in Food Science and Food Safety 2024; 23(1) doi: 10.1111/1541-4337.13292
|
11 |
Jing Li, Ai-hua Zhang, Fang-fang Wu, Xi-jun Wang. Alterations in the Gut Microbiota and Their Metabolites in Colorectal Cancer: Recent Progress and Future Prospects. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.841552
|
12 |
Ting Wang, Taichi Ishikawa, Minoru Sasaki, Toshimi Chiba. Oral and Gut Microbial Dysbiosis and Non-alcoholic Fatty Liver Disease: The Central Role of Porphyromonas gingivalis. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.822190
|
13 |
Rongrong Li, Jilu Shen, Yuanhong Xu. Fusobacterium nucleatum and Colorectal Cancer. Infection and Drug Resistance 2022; : 1115 doi: 10.2147/IDR.S357922
|
14 |
Dustin L. Higashi, Madeline C. Krieger, Hua Qin, Zhengzhong Zou, Elizabeth A. Palmer, Jens Kreth, Justin Merritt. Who is in the driver's seat? Parvimonas micra: An understudied pathobiont at the crossroads of dysbiotic disease and cancer. Environmental Microbiology Reports 2023; 15(4): 254 doi: 10.1111/1758-2229.13153
|
15 |
En-Hua Mei, Chao Yao, Yi-Nan Chen, Shun-Xue Nan, Sheng-Cai Qi. Multifunctional role of oral bacteria in the progression of non-alcoholic fatty liver disease. World Journal of Hepatology 2024; 16(5): 688-702 doi: 10.4254/wjh.v16.i5.688
|
16 |
Sima Ataollahi Eshkoor, Sara Fanijavadi. Dysbiosis–epigenetics–immune system interaction and ageing health problems.
Journal of Medical Microbiology
2024; 73(11) doi: 10.1099/jmm.0.001921
|
17 |
Ho Yin Pekkle Lam, Meng-Jiun Lai, Pin-Chun Wang, Wen-Jui Wu, Li-Kuang Chen, Hsiang-Wei Fan, Chun-Chieh Tseng, Shih-Yi Peng, Kai-Chih Chang. A Novel Bacteriophage with the Potential to Inhibit Fusobacterium nucleatum-Induced Proliferation of Colorectal Cancer Cells. Antibiotics 2025; 14(1): 45 doi: 10.3390/antibiotics14010045
|
18 |
Jialing Liu, Jiyang Jiang, Yue Lan, Chengyan Li, Ruiying Han, Jiao Wang, Tianyi Wang, Zhihe Zhao, Zhenxin Fan, Libang He, Jie Fang. Metagenomic analysis of oral and intestinal microbiome of patients during the initial stage of orthodontic treatment. American Journal of Orthodontics and Dentofacial Orthopedics 2024; 165(2): 161 doi: 10.1016/j.ajodo.2023.07.019
|